Tatva Chintan Pharma Chem consolidated net profit declines 78.06% in the September 2022 quarter
Sales decline 27.12% to Rs 90.09 crore
Net profit of Tatva Chintan Pharma Chem declined 78.06% to Rs 7.11 crore in the quarter ended September 2022 as against Rs 32.41 crore during the previous quarter ended September 2021. Sales declined 27.12% to Rs 90.09 crore in the quarter ended September 2022 as against Rs 123.62 crore during the previous quarter ended September 2021. ParticularsQuarter EndedSep. 2022Sep. 2021% Var.Sales90.09123.62 -27 OPM %12.4128.68 -PBDT11.3737.47 -70 PBT9.0635.42 -74 NP7.1132.41 -78Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Nov 04 2022 | 5:58 PM IST